Literature DB >> 20210751

Potential of nanoparticulate drug delivery systems by intranasal administration.

Javed Ali1, Mushir Ali, Sanjula Baboota, Jasjeet Kaur Sahani, Charles Ramassamy, Lé Dao.   

Abstract

Due to number of problems related with oral, parenteral, rectal and other routes of drug administration, the interest of pharmaceutical scientists has increased towards exploring the possibilities of intranasal delivery of various drugs. Nasal drug delivery system is commonly known for the treatment of local ailments like cold, cough, rhinitis, etc. Efforts have been made to deliver various drugs, especially peptides and proteins, through nasal route for systemic use; utilizing the principles and concepts of various nanoparticulate drug delivery systems using various polymers and absorption promoters. The incorporation of drugs into nanoparticles might be a promising approach, since colloidal formulations have been shown to protect them from the degrading milieu in the nasal cavity and facilitate their transport across the mucosal barriers. The use of nanoparticles for vaccine delivery provides beneficial effect, by achieving good immune responses. This could be due to the fact that small particles can be transported preferentially by the lymphoid tissue of the nasal cavity (NALT). The brain gets benefited through the intranasal delivery as direct olfactory transport bypasses the blood brain barrier and nanoparticles are taken up and conveyed along cell processes of olfactory neurons through the cribriform plate to synaptic junctions with neurons of the olfactory bulb. The intranasal delivery is aimed at optimizing drug bioavailability for systemic drugs, as absorption decreases with increasing molecular weight, and for drugs, which are susceptible to enzymatic degradation such as proteins and polypeptides. This review discusses the potential benefits of using nanoparticles for nasal delivery of drugs and vaccines for brain, systemic and topical delivery. The article aims at giving an insight into nasal cavity, consideration of factors affecting and strategies to improve drug absorption through nasal route, pharmaceutical dosage forms and delivery systems with examples of some patents for intranasal delivery, its advantages and limitations.

Entities:  

Mesh:

Year:  2010        PMID: 20210751     DOI: 10.2174/138161210791164108

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  20 in total

1.  Nanomaterials in controlled drug release.

Authors:  Xin-Jun Cai; Ying-Ying Xu
Journal:  Cytotechnology       Date:  2011-07-01       Impact factor: 2.058

Review 2.  Drug delivery systems, CNS protection, and the blood brain barrier.

Authors:  Ravi Kant Upadhyay
Journal:  Biomed Res Int       Date:  2014-07-20       Impact factor: 3.411

3.  Intranasal delivery of dexamethasone efficiently controls LPS-induced murine neuroinflammation.

Authors:  G Meneses; G Gevorkian; A Florentino; M A Bautista; A Espinosa; G Acero; G Díaz; A Fleury; I N Pérez Osorio; A Del Rey; G Fragoso; E Sciutto; H Besedovsky
Journal:  Clin Exp Immunol       Date:  2017-09-07       Impact factor: 4.330

4.  The impact of environmental metals in young urbanites' brains.

Authors:  Lilian Calderón-Garcidueñas; Alejandro Serrano-Sierra; Ricardo Torres-Jardón; Hongtu Zhu; Ying Yuan; Donna Smith; Ricardo Delgado-Chávez; Janet V Cross; Humberto Medina-Cortina; Michael Kavanaugh; Tomás R Guilarte
Journal:  Exp Toxicol Pathol       Date:  2012-03-19

5.  Role of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotype.

Authors:  Stacey L Demento; Weiguo Cui; Jason M Criscione; Eric Stern; Jacob Tulipan; Susan M Kaech; Tarek M Fahmy
Journal:  Biomaterials       Date:  2012-04-06       Impact factor: 12.479

6.  Brain delivery of valproic acid via intranasal administration of nanostructured lipid carriers: in vivo pharmacodynamic studies using rat electroshock model.

Authors:  Sharareh Eskandari; Jaleh Varshosaz; Mohsen Minaiyan; Majid Tabbakhian
Journal:  Int J Nanomedicine       Date:  2011-02-15

7.  Designing DNA nanodevices for compatibility with the immune system of higher organisms.

Authors:  Sunaina Surana; Avinash R Shenoy; Yamuna Krishnan
Journal:  Nat Nanotechnol       Date:  2015-09       Impact factor: 39.213

Review 8.  Macrophage reprogramming for therapy.

Authors:  Valentina M T Bart; Robert J Pickering; Philip R Taylor; Natacha Ipseiz
Journal:  Immunology       Date:  2021-01-25       Impact factor: 7.215

Review 9.  Stimuli Responsive, Programmable DNA Nanodevices for Biomedical Applications.

Authors:  Udisha Singh; Vinod Morya; Bhaskar Datta; Chinmay Ghoroi; Dhiraj Bhatia
Journal:  Front Chem       Date:  2021-06-30       Impact factor: 5.221

Review 10.  A review of the mechanism of injury and treatment approaches for illness resulting from exposure to water-damaged buildings, mold, and mycotoxins.

Authors:  Janette Hope
Journal:  ScientificWorldJournal       Date:  2013-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.